CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Anzalone Christopher Richard Chief Executive Officer | Sale | −1,000 | $64.96 | $65K | 3,921,644 |
| 2025-12-16 | Anzalone Christopher Richard Chief Executive Officer | Sale | −1,300 | $65.77 | $86K | 3,920,344 |
| 2025-12-16 | Anzalone Christopher Richard Chief Executive Officer | Sale | −166 | $66.77 | $11K | 3,920,178 |
| 2025-12-16 | Anzalone Christopher Richard Chief Executive Officer | Sale | −3,221 | $67.87 | $219K | 3,916,957 |
| 2025-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −100,532 | $68.67 | $6.9M | 4,000,723 |
| 2025-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −21,321 | $69.28 | $1.5M | 3,979,402 |
| 2025-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −8,147 | $69.96 | $570K | 3,971,255 |
| 2025-12-12 | Anzalone Christopher Richard Chief Executive Officer | Grant or award | +180,000 | 4,101,255 | ||
| 2025-12-05 | PERRY MICHAEL S Director | Sale | −16,250 | $61.03 | $992K | 115,240 |
| 2025-11-28 | Ferrari Mauro Director | Sale | −8,750 | $56.39 | $493K | 68,764 |
| 2025-10-01 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −20,000 | $35.00 | $700K | 212,122 |
| 2025-09-12 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −15,000 | $30.00 | $450K | 232,122 |
| 2025-09-02 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −15,000 | $25.00 | $375K | 247,122 |
| 2025-08-15 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −9,389 | $20.00 | $188K | 262,122 |
| 2025-08-13 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −611 | $20.00 | $12K | 271,511 |
| 2025-04-11 | Anzalone Christopher Richard Chief Executive Officer | Sale | −50,800 | $11.49 | $584K | 3,921,255 |
| 2025-04-10 | Anzalone Christopher Richard Chief Executive Officer | Sale | −50,000 | $10.87 | $544K | 3,972,055 |
| 2025-04-09 | Anzalone Christopher Richard Chief Executive Officer | Sale | −35,305 | $9.93 | $351K | 4,027,072 |
| 2025-04-09 | Anzalone Christopher Richard Chief Executive Officer | Sale | −3,400 | $10.75 | $37K | 4,023,672 |
| 2025-04-09 | Anzalone Christopher Richard Chief Executive Officer | Sale | −1,617 | $11.76 | $19K | 4,022,055 |
Page 5 of 28 · 542 trades